Corpus overview


MeSH Disease

Human Phenotype


There are no transmission terms in the subcorpus


There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page

    Severe immune thrombocytopenic purpura MESHD purpura HP in critical COVID-19: a case report

    Authors: Valérie Lévesque; Émilie Milaire; Daniel Corsilli; Benjamin Rioux-Massé; François Martin Carrier

    doi:10.21203/ Date: 2020-05-29 Source: ResearchSquare

    Purpose: COVID-19 is a new disease with many undescribed clinical manifestations. Material and methods: We report herein a case of severe immune thrombocytopenic purpura MESHD purpura HP (ITP) in a critical COVID-19 patient.Results: A patient presented a severe episode of immune thrombocytopenia MESHD thrombocytopenia HP (< 10 x 109/L) 20 days after admission for a critical COVID-19. This thrombocytopenia HP thrombocytopenia MESHD was associated with a life-threatening bleeding MESHD. Response to first-line therapies was delayed as it took up to 13 days after initiation of intravenous immunoglobulin and high dose dexamethasone to observe an increase in platelet count. Conclusion: COVID-19 may be associated with late presenting severe ITP. Such ITP may also be relatively resistant to first-line agents. Hematological manifestations of COVID-19, such as the ones associated with life-threatening bleeding MESHD, must be recognized. 

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
Human Phenotype

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.